Show simple item record

dc.contributor.authorRonald, D
dc.contributor.authorBarr, MRCP
dc.contributor.authorPhilip, J
dc.contributor.authorFialkow, MD
dc.date.accessioned2019-09-04T13:10:38Z
dc.date.available2019-09-04T13:10:38Z
dc.date.issued1973-08
dc.identifierhttp://www.nejm.org/doi/pdf/10.1056/NEJM197308092890608
dc.identifierhttp://hdl.handle.net/11295/91665
dc.identifier.citationN Engl J Med 1973; 289:307-309August 9, 1973en_US
dc.identifier.urihttps://library.adhl.africa/handle/123456789/7460
dc.description.abstractBONE-marrow cells from the majority of patients with chronic myelocytic leukemia have a specific and characteristic aberration of chromosome 22, called the Philadelphia (Ph1) chromosome.1 This abnormality, which may be found even before the onset of overt leukemia,2 is present throughout the course of clinical disease. Although the Ph1 chromosome probably is important in the pathogenesis of the disease the primary causes (which presumably are also the factors inducing the chromosome abnormality) remain largely unknown. An indirect approach to elucidating causative factors involves determining the number of cells from which chronic myelocytic leukemia arises. Single-cell (clonal) origin would be .........en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleClonal Origin of Chronic Myelocytic Leukemiaen_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record